dc.contributor | Departament de Salut |
dc.contributor.author | Programa d'Harmonització Farmacoterapèutica |
dc.date.accessioned | 2020-04-20T12:54:02Z |
dc.date.available | 2020-04-20T12:54:02Z |
dc.date.issued | 2020-04-19 |
dc.identifier.citation | Programa d'Harmonització Farmacoterapèutica. Coronavirus SARS-CoV-2: actualització de les recomanacions de tractament farmacològic de la pneumònia lleu-moderada [fullet]. Barcelona: Servei Català de la Salut; 2020. |
dc.identifier.uri | https://hdl.handle.net/11351/4865 |
dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Pneumonia mild-moderate; Pharmacological treatment; Hydroxychloroquine |
dc.description.abstract | Specific treatments for COVID-19 require pneumonia diagnosis and confirmation of SARS-CoV-2 coronavirus infection by PCR or rapid test. Although confirmed pneumonia treatment requires hospitalization, in some cases it may be necessary to start or continue pharmacological treatment of pneumonia in the out-of-hospital setting, as the specific treatment for COVID-19 is dispensed with exclusively. A circuit has been enabled to supply the medication in the out-of-hospital environment where necessary and that would otherwise meet the admission criteria. |
dc.language.iso | cat |
dc.publisher | Servei Català de la Salut |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pneumònia - Tractament |
dc.subject | COVID-19 (Malaltia) |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | Pneumonia |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Hydroxychloroquine |
dc.subject.mesh | Lopinavir |
dc.title | Coronavirus SARS-CoV-2: actualització de les recomanacions de tractament farmacològic de la pneumònia lleu-moderada [fullet] |
dc.type | info:eu-repo/semantics/other |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | neumonía |
dc.subject.decs | /tratamiento farmacológico |
dc.subject.decs | hidroxicloroquina |
dc.subject.decs | lopinavir |
dc.type.subtype | Fullet |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |